bivalent oral polio vaccine (bopv), type 1 and type 3 (BOPV) Report issue

Vaccine Approved FDA
AACT PubChem

Active Ingredient History

NOW
  • Now
Polio vaccines are vaccines used to prevent poliomyelitis (polio). Two types are used: an inactivated poliovirus given by injection (IPV) and a weakened poliovirus given by mouth (OPV). The World Health Organization (WHO) recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 33 in 2018.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data

Alternative names

bivalent oral polio vaccine | bivalent oral polio vaccine (bopv), type 1 and type 3 | bivalent oral poliovirus vaccine | bopv | live oral polio vaccine | opv | oral poliovirus vaccine | polio vaccine | poliovirus vaccine

Organizations (53)

Research & Development (53)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (36)

Approved Indications (1)


 

Poliomyelitis (approved 2009)

Experimental Indications - Clinical Trial Phases 1-4 (36)


 

Breast Neoplasms (Phase 2)

Colonic Neoplasms (Phase 2)

Colorectal Neoplasms (Phase 1)

COVID-19 (Phase 4)

Diabetes Mellitus, Type 1 (Phase 1)

Diphtheria (Phase 3)

Diphtheria Toxoid (Phase 3)

Enterovirus Infections (Phase 1)

Gastroenteritis (Phase 3)

Haemophilus Infections (Phase 3)

Haemophilus influenzae (Phase 3)

Haemophilus influenzae type b (Phase 3)

Healthy Volunteers (Phase 4)

Hepatitis B (Phase 3)

Immunity, Heterologous (Phase 4)

Influenza, Human (Phase 3)

Malaria (Phase 2)

Measles (Phase 3)

Melanoma (Phase 1)

Morbidity (Phase 4)

Mortality (Phase 4)

Pertussis Vaccine (Phase 3)

Pneumococcal Infections (Phase 3)

Poliomyelitis (Phase 4)

Poliovirus Vaccine, Oral (Phase 4)

Poliovirus Vaccines (Phase 4)

Prediabetic State (Phase 1)

Rotavirus Infections (Phase 3)

SARS-CoV-2 (Phase 3)

Severe Acute Respiratory Syndrome (Phase 3)

Tetanus (Phase 3)

Urinary Bladder Neoplasms (Phase 2)

Vaccination (Phase 4)

Vaccination Coverage (Phase 4)

Vaccines (Phase 4)

Whooping Cough (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 56
  • # of Trial Organizations: 53

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue